SAR445514

N/A

Report date: 2025/06/13 20:00:59

Base Information

Drug NameSAR445514
Drug Alias NameSAR445514SAR-445514IPH6401/SAR'514
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody
Mechanisms of ActionAnti-BCMANatural cytotoxicity triggering receptor 1 agonistsLow affinity immunoglobulin gamma Fc region receptor III-A agonists
TargetsB-cell maturation proteinNatural cytotoxicity triggering receptor 1Low affinity immunoglobulin gamma Fc region receptor III-A
Therapy Area/IndicationsMultiple MyelomaImmunoglobulin Light-chain Amyloidosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumItaly +[7] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsMultiple MyelomaImmunoglobulin Light-chain Amyloidosis

Other Information

ATC CodeN/A
Related LinksN/A